Shearman & Sterling LLP multinational law firm headquartered in New York City, United States.

balance scale

Feb 05, 2014

FTC Workshop Seeks to Spark Biosimilars Competition

Subscribe

Jump to...

 
Demand for biologics is growing fast, but even after Congress passed authorizing legislation in 2010, the pace of generic entry appears to have stalled. Seeking to spur increased generic competition, the FTC held an all-day workshop earlier this week to discuss evolving FDA and state regulations, especially on the key issues of substitutability and naming rules for follow-on biologics. While the workshop participants did not reach consensus, the debate was lively and provided much for the FTC to consider as it continues to examine and weigh in on the topic.

View memo, FTC Workshop Seeks to Spark Biosimilars Competition

Authors and Contributors

Wayne Dale Collins

Of Counsel

Antitrust

+1 212 848 4127

+1 212 848 4127

Washington DC

Jessica K. Delbaum

Partner

Antitrust

+1 212 848 4815

+1 212 848 4815

New York

Geert Goeteyn

Partner

Antitrust

+32 2 500 9800

+32 2 500 9800

Brussels

Matthew Readings

Partner

Antitrust

+44 20 7655 5937

+44 20 7655 5937

London

Practices